tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

SGMT Stock Latest News

Sagimet: Advancing FASN Inhibitor Pipeline and Solid Cash Position Support Buy Rating and $26 Target
RatingsSagimet: Advancing FASN Inhibitor Pipeline and Solid Cash Position Support Buy Rating and $26 Target
11d ago
SGMT
Sagimet: Underappreciated, De-Risked Pipeline with Near-Term Milestones Supports Buy Rating
PremiumRatings
Sagimet: Underappreciated, De-Risked Pipeline with Near-Term Milestones Supports Buy Rating
11d ago
SGMT
Sagimet: Undervalued MASH and Acne Pipeline with Best-in-Class Combination Potential Supports Buy Rating
PremiumRatings
Sagimet: Undervalued MASH and Acne Pipeline with Best-in-Class Combination Potential Supports Buy Rating
12d ago
SGMT
Sagimet Biosciences Reports 2025 Results, Highlights Clinical Progress
PremiumCompany Announcements
Sagimet Biosciences Reports 2025 Results, Highlights Clinical Progress
12d ago
8K
SGMT
Sagimet Biosciences reports Q4 EPS (29c), consensus (43c)
PremiumThe Fly
Sagimet Biosciences reports Q4 EPS (29c), consensus (43c)
12d ago
SGMT
Adobe downgraded, Palantir upgraded: Wall Street’s top analyst calls
PremiumThe FlyAdobe downgraded, Palantir upgraded: Wall Street’s top analyst calls
2M ago
V
MA
Sagimet Biosciences initiated with a Buy at Guggenheim
Premium
The Fly
Sagimet Biosciences initiated with a Buy at Guggenheim
2M ago
SGMT
Sagimet Biosciences price target raised to $37 from $29 at Clear Street
Premium
The Fly
Sagimet Biosciences price target raised to $37 from $29 at Clear Street
2M ago
SGMT
Sagimet Therapeutics: Strengthened FASN-Inhibition Safety Profile and Advancing Phase 2 Programs Support Buy Rating
PremiumRatings
Sagimet Therapeutics: Strengthened FASN-Inhibition Safety Profile and Advancing Phase 2 Programs Support Buy Rating
2M ago
SGMT
Sagimet Biosciences Reports Positive Phase 3 Acne Data
PremiumCompany Announcements
Sagimet Biosciences Reports Positive Phase 3 Acne Data
2M ago
8K
SGMT
Sagimet Biosciences announces license partner Ascletis issues results for ASC40
PremiumThe Fly
Sagimet Biosciences announces license partner Ascletis issues results for ASC40
2M ago
SGMT
Multiple Shots on Goal: Sagimet’s Differentiated MASH Combo and Acne Franchise Underpin Buy Rating and Favorable Risk‑Reward
PremiumRatings
Multiple Shots on Goal: Sagimet’s Differentiated MASH Combo and Acne Franchise Underpin Buy Rating and Favorable Risk‑Reward
2M ago
SGMT
Sagimet Biosciences initiated with an Equal Weight at Barclays
PremiumThe FlySagimet Biosciences initiated with an Equal Weight at Barclays
2M ago
SGMT
Sagimet Biosciences: Advancing FASN Inhibitor Pipeline and Multi-Indication Opportunities Support Buy Rating and $26 Target
Premium
Ratings
Sagimet Biosciences: Advancing FASN Inhibitor Pipeline and Multi-Indication Opportunities Support Buy Rating and $26 Target
2M ago
SGMT
3 ‘Strong Buy’ Biotech Stocks to Buy Now, According to Top Analysts
Premium
Market News
3 ‘Strong Buy’ Biotech Stocks to Buy Now, According to Top Analysts
3M ago
PYXS
RGNX
Sagimet Highlights Positive MASH Combo Data and Pipeline Progress
PremiumCompany Announcements
Sagimet Highlights Positive MASH Combo Data and Pipeline Progress
3M ago
8K
SGMT
Sagimet announces results from Phase 1 PK trial of denifanstat, resmetirom
PremiumThe Fly
Sagimet announces results from Phase 1 PK trial of denifanstat, resmetirom
3M ago
SGMT
Strategic Licensing and Pipeline Advancements Drive Buy Rating for Sagimet Biosciences
PremiumRatings
Strategic Licensing and Pipeline Advancements Drive Buy Rating for Sagimet Biosciences
3M ago
SGMT
Sagimet Biosciences enters global license agreement with TAPI
PremiumCompany Announcements
Sagimet Biosciences enters global license agreement with TAPI
3M ago
8K
SGMT
Sagimet Biosciences announces China’s NMPA accepted NDA for denifanstat
PremiumThe FlySagimet Biosciences announces China’s NMPA accepted NDA for denifanstat
3M ago
SGMT
Buy Rating for Sagimet Biosciences: Promising Pipeline Developments and Strong Financial Position
Premium
Ratings
Buy Rating for Sagimet Biosciences: Promising Pipeline Developments and Strong Financial Position
4M ago
SGMT
3 Best Stocks to Buy Now, 11/26/2025, According to Top Analysts
Premium
Market News
3 Best Stocks to Buy Now, 11/26/2025, According to Top Analysts
4M ago
UPB
CLSK

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >